|
Volumn 363, Issue 9403, 2004, Pages 164-165
|
Dried blood spot technology for CD4+ T-cell counting [1] (multiple letters)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBODY;
ANTIVIRUS AGENT;
CD4 ANTIGEN;
VIRUS RNA;
ANTIBODY LABELING;
BIOLOGICAL MONITORING;
BIOTECHNOLOGY;
BLOOD ANALYSIS;
BLOOD SAMPLING;
CELL ASSAY;
CELL POPULATION;
CELL SURFACE;
COMMERCIAL PHENOMENA;
COST EFFECTIVENESS ANALYSIS;
DEVELOPED COUNTRY;
DEVICE;
ENZYME LINKED IMMUNOSORBENT ASSAY;
EOSINOPHIL;
FLOW CYTOMETRY;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
LYMPHOCYTE COUNT;
MONOCYTE;
PARASITOSIS;
PREVALENCE;
PRIORITY JOURNAL;
REPRODUCIBILITY;
STANDARDIZATION;
T LYMPHOCYTE;
TUBERCULOSIS;
ANALYTICAL EQUIPMENT;
BLOOD;
CD4 LYMPHOCYTE COUNT;
CD4+ T LYMPHOCYTE;
CYTOLOGY;
DEVELOPING COUNTRY;
ECONOMICS;
INSTRUMENTATION;
LABORATORY DIAGNOSIS;
METHODOLOGY;
NOTE;
STANDARD;
COMPARATIVE STUDY;
GENETICS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
ISOLATION AND PURIFICATION;
SENSITIVITY AND SPECIFICITY;
STATISTICS;
BLOOD;
CD4 LYMPHOCYTE COUNT;
CD4-POSITIVE T-LYMPHOCYTES;
DEVELOPING COUNTRIES;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FLOW CYTOMETRY;
HIV INFECTIONS;
HUMANS;
REAGENT KITS, DIAGNOSTIC;
SPECIMEN HANDLING;
HIV-1;
RNA, VIRAL;
SENSITIVITY AND SPECIFICITY;
|
EID: 1542376684
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(03)15272-5 Document Type: Letter |
Times cited : (16)
|
References (3)
|